Cardiovascular disease prevention, blood pressure, cholesterol, and heart function
421 articles
Breakthrough siRNA therapy dramatically reduces lipoprotein(a), a stubborn cardiovascular risk factor resistant to statins and lifestyle changes.
New meta-analysis shows PCSK9 inhibitors significantly reduce cardiovascular events and major amputations in PAD patients beyond standard statin therapy.
New research shows most children with inherited high cholesterol go undiagnosed, missing critical early intervention opportunities.
Inclisiran, a breakthrough RNA therapy, dramatically lowered dangerous cholesterol levels in real-world patients with minimal side effects.
Advanced cholesterol-lowering therapies show promise for dramatically reducing cardiovascular disease risk through innovative approaches.
Major analysis of 49,847 patients shows PCSK9 inhibitors significantly reduce heart attacks and strokes beyond standard statin therapy.
New research reveals how regular exercise protects against aortic dissection, a life-threatening cardiovascular emergency.
New mouse study challenges assumptions about triglycerides and aortic health, finding no increased risk of thoracic aneurysms.
Scientists discover how a molecular switch in blood vessel cells accelerates aging and plaque formation, revealing new therapeutic targets.
Major review reveals sleep quality affects cardiovascular health beyond just duration. Multiple sleep factors impact heart disease risk.
Inefficient cellular cleanup in the heart creates inflammation that damages non-regenerative heart muscle cells.
New research reveals how good cholesterol forms diverse protective particles through a key cellular transporter mechanism.
